🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hui‐Ming Lin

Garvan Institute of Medical Research

ORCID: 0000-0003-4892-6008

Also affiliated with St Michael’s Hospital, Ente Ospedaliero Cantonale, Institute of Oncology Research, Unity Health Toronto

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer”.

Aberrations in circulating ceramide levels are associated with poor clinical outcomes across localised and metastatic prostate cancer

Prostate Cancer and Prostatic Diseases(2021)10.1038/s41391-021-00338-z

N/A

0DataRank · unranked

32 citations

Kevin Huynh, Manish Kohli, Winston Tan, Arun Azad, Nicole Yeung +12 more

Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer

BMC Medicine(2022)10.1186/s12916-022-02298-0

N/A

0DataRank · unranked

21 citations

Hui‐Ming Lin, Edmond M. Kwan, Heidi Fettke, Ben Tran, Ian D. Davis +22 more

Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance

Journal of Clinical Investigation(2024)10.1172/jci183583

N/A

0DataRank · unranked

7 citations

Robert Diaz, Hui‐Ming Lin, Evan Roberts, Lisa G. Horvath, Andrew Martin +7 more